A consensus report on the diagnosis and treatment of early puberty;Consenso sobre el diagnóstico y tratamiento de la pubertad precoz central

Revista Medica de Chile

Volumn 131, Issue 1, 2003, Pages 95-110

  García B, Hernán ^a   Youlton R, Ronald ^b   Burrows A , Raquel ^c   Catanni O, Andreína ^d  

^a HOSPITAL SAN BORJA ARRIARÁN   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

^d PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Gonadorelin; Hypothalamo Hypophyseal System; Puberty; Puberty Preococious

Indexed keywords

GONADORELIN DERIVATIVE; DRUG DERIVATIVE; GONADORELIN; LUTEINIZING HORMONE;

ADRENARCHE; BODY GROWTH; BONE AGE; BONE MATURATION; BREAST DEVELOPMENT; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DISTRESS SYNDROME; EMOTIONAL STRESS; EPIPHYSIS; GROWTH INHIBITION; GROWTH RATE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMAGING SYSTEM; NUCLEAR MAGNETIC RESONANCE; PRECOCIOUS PUBERTY; PUBERTY; SHORT STATURE; STEROID BLOOD LEVEL; TESTIS DEVELOPMENT; TREATMENT INDICATION; ULTRASOUND; ADOLESCENT; ARTICLE; BLOOD; BODY HEIGHT; CHILD; FEMALE; MALE; PRACTICE GUIDELINE;

ADOLESCENT; BODY HEIGHT; CHILD; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEINIZING HORMONE; MALE; PUBERTY, PRECOCIOUS;

EID: 0038282792     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (96)

1. FONTOURA M, BRAUNER R, PREVOT C, RAPPAPORT R. Precocious puberty in girls: early diagnosis of a slowly progressing variant. Arch Dis Child 1989; 64: 1170-6.
2. ROSENFIELD RL. Selection of children with precocious puberty for treatment with gonadotropin releasing hormone analogs. J Pediatr 1994; 124: 989-91.
3. MERKE DP, CUTLER GB JR. Evaluation and management of precocious puberty. Arch Dis Child 1996; 75: 209-71.
4. MARSHALL WA, TANNER JM. Variations in the pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291-303.
5. MARSHALL WA, TANNER JM. Variation in the pattern of puberal changes in boys. Arch Dis Child 1970; 45: 13-23.
6. ROGOL A, BLIZZARD R. Variations and disorders of pubertal development. En: Wilkins ed Charles Thomas. Springfield, Illinois. The diagnosis and treatment of endocrine disorders in chilhoood and adolescence, 1996; 857-917.
7. HERMAN-GIDDENS ME, SLORA EJ, WASSERMAN RC, BOURDONY CJ, BHAPKAR MV, KOCH GG ET AL. Secondary sexual characteristics and menses in young girls seen in office practice: A study from the pediatric research in office setting network. Pediatrics 1997; 99: 505-12.
8. KAPLOWITZ PB, OBERFIELD SE. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society. Pediatrics 1999; 104: 936-41.
9. SLYPER AH. Childhood obesity, adipose tissue distribution, and the pediatric practitioner. Pediatrics. 1998; 102: 131 p.e4.
10. HEGER S, PARTSCH CJ, PETER M, BLUM WF, KIESS W, SIPPEL WG. Serum leptin levels in patient with progressive central precocious puberty. Pediatr Res 1999; 46: 71-5.
11. KAPLOWITZ PB, SLORA E, WASSERMAN R, PEDLOW S, HERMAN-GIDDENS M. Earlier onset of puberty in girls: Relation to increased body mass index and race. Pediatrics 2001; 108: 347-53.
12. GAETE X, UNUANE N, AVILA A, CASSORLA F. Cambios en la edad de inicio de la pubertad en niñas de la comuna de Santiago. Implicancias para el diagnóstico de la pubertad precoz. Rev Chil Pediatr 2002; 73: 341-7.
13. HERMAN-GIDDENS ME, WANG L, KOCH G. Secondary sexual characteristics in boys. Estimates from the National Health and Nutrition Examinations Survey III, Arch Pediatr Adolesc Med 2001; 155: 1022-8.
14. JAKA A, YOULTON R, VALLADARES L, GARCÍA H, CATTANI A, VENEGAS P ET AL. Telarquia prematura. Rev Chil Pediatr 1995; 66: 89-92.
15. ARITAKI S, TAKAGI A, SOMEYA H, JUN L. A comparison of patients with premature thelarche and idiophatic true precocius puberty in the initial stage of illnes. Act Pediatr Jpn 1997; 39: 21-7.
16. VAN WINTER JT, NOLLER KL, ZIMMERMAN D, MELTON JL. Natural history of premature thelarche in Olmsted county, Minnesota, 1940 to 1980. J Pediatr 1990; 116: 278-80.
17. VOLTA C, BERNASCONI S, CISTERNINO M, BUZI F, FERZETTI A, STREET ME ET AL. Isolate premature thelarche and thelarque variant: clinical an auxiologic follow up of 119 girls. J Endocrinol Invest 1998; 21: 180-3.
18. VERROTI A, FERRARI M, MORGESE G, CHIARELLI F. Premature thelarche: a long-term follow up. Gynecol Endocrinol 1996; 10: 241-7.
19. STANHOPE R, BROOK CGD. Premature thelarche variant: A new condition of sexual maturation? Acta Endocrinol 1990; 123: 481-6.
20. GARIBALDI LR, ACETO T, WEBER C. The Pattern of gonadotrophin and estradiol secretion in exaggerated thelarche. Acta Endocrinol 1993; 128: 345-50.
21. PASQUINO AM, PUCARELLI I, PASSERI F, SEGNI M, MANCINI MA, MUNNICHI G ET AL. Progression of premature thelarche to central precocious puberty. J Pediatr 1995; 126: 11-4.
22. COHEN A, ZECCA S, GAGGERO M, DASSORI A, PARODI L, MARTELLA M ET AL. Premature thelarche: the long-term follow-up. Horm Res 1996; 46 (Suppl 2): 104.
23. ROMAN R, JHONSON C, BORIC A, AVILA A, CODNER E, CASSORLA F. G Protein activating mutations may cause cases of exaggerated thelarche. Ped Res 2001; 49: 144A.
24. GARCÍA H. Fitpestrógenos: Una nueva preocupacion en la alimentación infantil. Rev Chil Pediatr 1999; 70: 92-9.
25. GARCÍA H, YOULTON R, VALLADARES L, JARA A, CATTANI A, TJIMES M ET AL. Telarquia prematura: Aumento actividad estrogénica en el plasma. Rev Chil Pediatr 1995; 66: 83-8.
26. Pescovitz OH, Hench KD, Barnes KM, Loriaux DL, Cutler GB JR. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone. J Clin Endocrinol Metab 1988; 67: 474-9.
27. IBÁÑEZ L, VIRDIS R, POTAU N, ZAMPOLLI M, GHIZZONI L, ALBISU MA ET AL. Natural history of premature pubarche: An auxological study. J Clin Endocrinol Metab 1992; 74: 254-7.
28. IBÁÑEZ L, POTAU N, VIRDIS R, ZAMPOLLI M, TERZI C, GUSSYNIÉ M ET AL. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993; 76: 1599-603.
29. IBÁÑEZ L, POTAU N, ZAMPOLLI M, RIQUE S, SAENGER P, CARRASCOSA A. Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 1997; 82: 2283-8.
30. GREULICH WW, PYLE SI. Radiographic atlas of skeletal development of the hand and wrist. Stanford, CA: Stanford University Press, 1959.
31. TANNER JM, WHITEHOUSE RH, CAMERON N, MARSHALL WA, HEALY MJR, GOLDSTEIN H. Assessment of skeletal maturity and prediction of adult height (TW2 method) 2nd Edition. London. Academic Press Limited; 1983.
32. GARCÍA C, GARCÍA H. Utilidad de la radiografía para determinar la edad ósea. Pediatría al día 1995; 5: 258-60.
33. BAYLEY N, PINNEAU SR. Tables for predicting adult height from skeletal age: revised use with the Greulich-Pyle hand standards. J Pediatr 1952; 40: 423-41.
34. GARCÍA H. Utilidad de la predicción de talla en población iberoamericana. En: Variantes normales del crecimiento. México: Calzada R. ed. Panamericana, 1996; 119-126.
35. PREECE MA. Prediction of adult height. Methods and problems. Acta Pediatr Scand 1988; 347 (Suppl): 4-11.
36. STANHOPE R. UK premature thelarche: Clinical follow-up and indication for treatment. J Ped Endocrinol Metab 2000, 13: 827-30.
37. OERTER KE, URIATE MM, ROSE SR, BARNES KM, CUTLER GB JR. Gonadotropin secretory dynamics during puberty in normal girls and boys. J Clin Endorinol Metab 1990; 71: 3539-44.
38. NEELY E, HINTZ R, WILSON D, LEE P, GAUTLER T, ARGENTE ET AL. Normal ranges for immunochemiluminometric gonadotropin assays. J Pediatr 1995; 127: 1, 40-46.
39. KLEIN KO, BARON J, BARNES KM, PESCOVITZ OH, CUTLER GB JR. Use of an ultrasensitive recombinant cell bioassay to determine estrogen levels in girl with precocious puberty treated with a luteinizing hormone-releasing hormone agonist. J Clin Endocrinol Metab 1998; 83: 2387-9.
40. LEE PA. Laboratory monitoring of children with precocious puberty. Arch Pediatr Adolesc Med 1994; 148: 369-76.
41. ECKERT KL, WILSON DM, BACHRACH LK, ANHALT H, HABIBY RL, OLNEY RC ET AL. A single-sample, subcutaneous gonadotropin-releasing hormone test for central precocious puberty. Pediatrics 1996; 97: 517-9.
42. GARIBALDI LR, ACETO T JR, WEBER C, PANG S. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test. J Clin Endocrinol Metab 1993; 76: 851-6.
43. POTAU N, IBÁÑEZ L, SENTIS M, CARRASCOSA A. A sexual dimorphism in the maturation of the pituitary-gonadal axis, assessed by GnRH agonist challenge. Eur J Endocrinol 1999; 141: 27-34.
44. BRITO VN, BATISTA MC, BORGES MF, LATROCINIO AC, KOHEK MBF, THIRONE ACP ET AL. Diagnostic value of fluorometric assays in the evaluation of precocious puberty. J Clin Endocrinol Metab 1999; 84: 3539-44.
45. IUGHETTI L, PREDIERI B, FERRARI M, GALLO C, LIVIO L, MILIOLI S ET AL. Diagnosis of central precocious puberty: Endocrine assessment. J Pediatr Endocrinol Metab 2000; 13: 709-16.
46. PALMERT MR, MALIN HV, BOEPPLE PA. Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients. J Clin Endocrinol Metab 1999; 84: 415-23.
47. CISTERNINO M, ARRIGO T, PASQUINO AM, TINELLI C, ANTONIAZZI F, BEDUSCHI L ET AL. Etiology and age incidence of precocious puberty in girls: A Multicentric Study, J Pediatr Endocrinol Metab 2000, 13: 695-701.
48. DE SANCTIS V, CORRIAS A, RIZZO V, BERTELLONI S, URSO L, GALLUZZI F ET AL. Etiology of central precocious puberty in males: The results of the Italian Study Group for Physiopathology of Puberty. J Pediatr Endocrinol Metab 2000; 13: 687-94.
49. HAHACHOKLERTWATTANA P, KAPLAN SL, GRUMBACH MM. The luteinizing hormone-releasing hormone-secreting hypothalamic hamartoma is a congenital malformation: natural history. J Clin Endocrinol Metab 1993; 77: 118-24.
50. URIARTE MN, KLEIN KO, BARNES KM, PESCOVITZ OH, LORIAUX DL, CUTLER GB JR. Gonadotrophin and prolactin secretory dynamics in girls with normal puberty, idiopathic precocious puberty and precocious puberty due to hypothalamic hamartoma. Clin Endocrinol 1998; 49: 363-8.
51. CACCIARI E, ZUCCHINI S, AMBROSETTO P, TANI G, CARLA G, CICOGNANI A ET AL. Empty sella in children and adolescents with possible hypothalamic pituitary disorders. J Clin Endocrinol Metab 1994; 78: 767-71.
52. CASSIO A, CACCIARI E, ZUCCHINI S, BALSAMO A, DIEGOLI M, ORSINI F. Central Precocious Puberty: Clinical and Imaging Aspects. J Pediatr Endocrinol Metab 2000; 13: 703-8.
53. OERTER KLEIN K. Precocious puberty: Who has it? Who should be treated? J Clin Endocrinol Metab 1999; 73: 1235-40.
54. CROWLEY WF JR, COMITTE F, VALE W, RIVIER J, LORIAUX DL, CUTLER GB. Therapeutic use of pituitary desensitization with a long-acting LHRH agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab 1981; 52: 370-2.
55. BELCHETZ PE, PLANT TM, NAKAI YKEOG EJ, KNOBIL E. Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science 1978; 202: 631-3.
56. LAHLOU N, CAREL J-C, CHAUSSAIN J-L, ROGER M. Pharmacokinetics and pharmacodynamics of GnRH agonist: Clinical Implications in Pediatrics. J Pediatr Endocrinol Metab 2000; 13: 723-37.
57. PARKER KL, BAENS-BAILON RG, LEE PA. Depot leuprolicle acetate dosage for sexual precocity. J Clin Endocrinol Metab 1991; 73: 50-2.
58. TANAKA T, HIBI I, KATO S, SAITO S, SHIMIZU N, SUWA S ET AL. A dose finding study of a super long-acting luteinizing hormone-releasing hormone analog (leuprolide acetate depot, TAP-144 SR) in the treatment of central precocious puberty. The TAP-144-SR CPP Study Group. Endocrinol Jpn 1991; 38: 369-76.
59. TONINI G, LAZZERINI M. Side effects of GnRH analogue treatment in childhood. J Pediatr Endocrinol Metab 2000; 13: 795-803.
60. LAZAR A, PERTZELAN A. Early polycystic ovary-like syndrome in girls with central precocious puberty and exaggerated adrenal response. Eur J Endocrinol 1995; 133: 403-6.
61. STYNE DM. New aspects in the diagnosis and treatment of pubertal disorders. Pediatr Clin North Am 1997; 44: 505-21.
62. JENSEN A-MB, BROCKS V, HOLM K, LAURSEN EM, MÜLLER J. Central precocious puberty in girls: Internal genitalia before, during and after treatment with long-acting gonadotropin-releasing hormone analogues. J Pediatr 1998; 132: 105-8.
63. PARTSCH CJ, HEGER S, SIPPELL WG AND THE GERMAN DECAPEPTYL STUDY GROUP. Treatment of Central Precocious Puberty: Lessons from a 15 Years Prospective Trial. J Pediatr Endocrinol Metab 2000; 13: 747-58.
64. OOSTDIJK W, RIKKEN B, SCHREUDER S, OTTEN B, ODINK R, ROUWE C ET AL. Final height in central precocious puberty after long term treatment with a slow release GnRH agonist. Arch Dis Child 1996; 75: 292-7.
65. PAUL D, CONTE FA, GRUMBACH MM, KAPLAN SL. Long term effect of gonadotropin-releasing hormone agonist therapy on final height and near final height in 26 children with true precocious puberty treated at a median age of less, than 5 years. J Clin Endocrinol 1995; 80: 546-51.
66. KAULI R, KORNREIGH L, LAKON Z. Pubertal development, growth and final height in girls with sexual precocity after therapy with the GnRH analogue D-Trp-6-LHRH. Horm Res 1990; 33: 11-7.
67. BRAUNER R, ADAN L, MALANDRY F, ZANTLEIFER D. Adult height in girls with true precocious puberty. J Clin Endocrinol Metab 1994; 79: 415-20.
68. OERTER KE, MANASCO PK, BARNES KM, JONES J, HILL S, CUTLER GB JR. Effects of luteinizing hormone-releasing hormone agonists on final height in luteinizing hormone-releasing hormone-dependent precocious puberty. Acta Paediatr 1993; Suppl 388: 62-8.
69. ANTONIAZZI F, ARRIGO T, CISTERNINO M, GALLUZZI F, BERTELLONI S, PASQUINO AM ET AL. End results in central precocious puberty with GnRH analog treatment: The data of the Italian Study Group for physiopathology of puberty. J Pediatr Endocrinol & Metab 2000; 13: 773-80.
70. MUL FD, OOSTDIJK W, OTTEN BJ, ROUWE C, JANSEN M, DELEMARRE-VAN DE WAAL J ET AL. Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: The Dutch experience. J Pediatr Endocrinol Metab 2000; 13: 705-72.
71. GALLUZZI F, SALTI R, BINDI G, PASQUINI E, LA CAUSA C. Adult height comparison between boys and girls with precocious puberty after long-term gonadotrophin-releasing hormone analogue therapy. Acta Paediatr 1998; 87: 521-7.
72. MICILLO M, SALERNO M, OFFICIOSO A, PERNA E, GASPARINI N, PISATURO L ET AL. Near final height after GnRH agonist treatment in central precocious puberty. J Pediatr Endocrinol Metab 2000; 13: 787-90.
73. CACCIARI E, CASSIO A, BALSAMO A, COLLI C, CICOGNANI A, PIRAZZOLI P ET AL. Long-term follow-up and final height in girls with central precocious puberty treated with luteinizing hormone-releasing hormone analogue nasal spray. Arch Pediatr Adolesc Med 1994; 148: 1194-9.
74. OOSTDIJK W, DROP SLS, ODINK RJH, HUMMELINK R, PARSTCH CJ, SIPELL WG ET AL. Long-term results with a slow-release gonadotropin-releasing hormone agonist in central precocious puberty. Acta Paediatr Scand Suppl 1991; 372: 39-45.
75. KLETTER GB, KELCH RP. Effect of gonadotropin-releasing hormone analog therapy on adult sta ture in precocious puberty. J Clin Endocrinol Metab 1994; 79: 331-4.
76. CASSIO A, CACCIARI E, BALSAMO A, BAL M, TASSINARI D. Randomized trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5-8.5 years. Arch Dis Child 1999; 81: 329-32.
77. BOUVATIER C, COSTE J, RODRIGUE D, TEINTURIER C, CAREL JC, CHAUSSAIN JL ET AL. Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study. J Clin Endocrinol Metab 1999; 84: 3575-8.
78. LAZAR L, KAULI A, PERETZELAN, PHILLIP M. Gonadotropin-Supressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height. J Clin Endocrinol Metab 2002; 87: 2090-4.
79. ARRIGO T, CISTERNINO M, GALLUZZI F, BERTELLONI S, PASQUINO AM, ANTONIAZZI F ET AL. WHEN TO STOP GnRH Analog Therapy: The Experience of the Italian Study Group for Physiopathology of Puberty. J Pediatr Endocrinol Metab 2000; 13: 759-64.
80. RIZZO V, DE SANCTIS V, CORRIAS A, FORTINI M, GALLUZZI F, BERTELLONI S, GUARNERI MP, POZZAN G, CISTERNINO M, PASQUINO AM ET AL. Factors influencing final/near-final height in 12 boys with central precocious puberty treated with gonadotropinreleasing hormone agonists. J Pediatr Endocrinol Metab 2000; 13: 781-90.
81. ARRIGO T, CISTERNINO M, GALLUZI F, BERTELLONI S, PASQUINO AM, ANTONIAZZI F ET AL. Analysis of the factors affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. Eur J Endocrinol 1999; 141: 140-4.
82. CAREL JC, ROGER M, ISPAS S, TONDU F, LAHLOU N, BLUMBERG J ET AL. Final height after long-term treatment with Triptorelin slow release for central precocious puberty: Importance of statural growth after interruption of treatment. J Clin Endocrinol Metab 1999; 84: 1973-8.
83. OHYAMA K, TANAKA T, TACHIBANA K, NIIMI H, FUJIEDA K, MATSUO N ET AL. Timing for discontinuation of treatment witha long-acting gonadotropin-releasing hormone analog in girls with central precocious puberty. TAP-144SR CPP Study Group Endocr J 1998; 45: 351-6.
84. BOOT MA, DE MUINCK KEIZER-SCHRAMA SMPF, POLS HAP, KRENNING EP, DROP SLS. Bone mineral density and body composition before and during treatment with gonadotropin-releasing hormone agonist in children with central precocious and early puberty. J Clin Endocnnol Metab 1998; 83: 370-3.
85. CHIUMELLO G, BRAMBILLA P, GUARNERI MP, RISSO G, MANZONI P, SGARAMELLA P. Precocious puberty and body composition: Effects of GnRH analog treatment. J Pediatr Endocnnol Metab 2000; 13: 791-4.
86. MANASCO PK, PESCOWITZ OH, BLIZZARD RM. Local reactions to depot leuprolidre therapy for central precocious puberty (letter). J Pediatr 1993; 123: 334-5.
87. SAGGESE G, BERTELLONI S, BAHONCELLI GI, BATTINI R, FRANCHI G. Reduction of bone density: an effect of gonadotropin releasing hormone analogue treatment in central precocious puberty. Eur J Pediatr 1993; 152: 717-20.
88. BERTELLONI S, BARONCELLI GI, SORRENTINO MC, PERRI G, SAGGESE G. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females. Eur Pediatr 1998; 57: 363-7.
89. ANTONIAZZI F, BERTOLDO F, LAURIOLA S, SIRPRESI S, GASPERI E, ZAMRONI G ET AL. Prevention of bone demineralization by calcium supplementation in precocious puberty during gonadotropin-releasing hormone agonist treatment. J Clin Endocrinol Metab 1999; 84: 1992-6.
90. HEGER S, PARTSCH C-J, SIPPELL WG. Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. J Clin Endocrinol Metab 1999; 84: 4583-90.
91. REZNIK Y, CHAPON F, LAHLOU N, DEBOUCHER N, MAHOUDEAU J ET AL. Pituitary apoplexy of a gonadotroph adenoma following gonadotropin releasing hormone agonist therapy for prostatic cancer. J Endocrinol Invest 1997; 20: 566-8.
92. SCHROOR EJ, VAN WEISSENBRUCH M, DELEMARRE-VAN DE WAAL HA. Long-term GnRH-agonist treatment does not postpone central development of the GnRH pulse generator in girls with idiopathic precocious puberty. J Clin Endocrinol Metab 1995; 80: 1696-701.
93. FEUILLAN PP, JONES JV, BARNES K, OERTER-KLEIN K, CUTLER GB JR. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: Long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty. J Clin Endocrinol Metab 1999; 84: 44-9.
94. JAY N, MANSFIELD MJ, BLIZZARD R, CROWLEY WF JR, SCHOENFELD D, RHUBIN L ET AL: Ovulation and menstrual function of adolescents girls with central precocius puberty after therapy with gonadotropin realising hormone agonists. J Clin Endocrinol Metab 1992; 75: 890-4.
95. ABODOVSKY N, MATUS DE, LA PARRA A, VIVANCO X, ONETTO E. Tratamiento de la pubertad precoz con medroxiprogesterona. Bol Med Hosp Infant Mex 1979; 36: 581-97.
96. LARON Z, KAULI R. Experience with cyproterone acetate in the treatment of precocius puberty. J Pediatr Endocrinol Metab 2000; 13: 805-19.